Click for best price
Breast Cancer Diagnostic Technologies Market Size, Share 2023
Breast cancer diagnosis and treatment are best accomplished by a team of experts working together with the patient.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Diagnostic Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Diagnostic Technologies. This report contains market size and forecasts of Breast Cancer Diagnostic Technologies in global, including the following market information:
Global Breast Cancer Diagnostic Technologies Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Breast Cancer Diagnostic Technologies market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Mammography Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Breast Cancer Diagnostic Technologies include Abbvie, Abbott, Bristol-Myers Squibb, Agilent Technologies, Novartis and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Breast Cancer Diagnostic Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Diagnostic Technologies Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Breast Cancer Diagnostic Technologies Market Segment Percentages, by Type, 2022 (%)
Mammography
Biopsy
Companion Diagnostics
Global Breast Cancer Diagnostic Technologies Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Breast Cancer Diagnostic Technologies Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Breast Cancer Diagnostic Technologies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Breast Cancer Diagnostic Technologies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Breast Cancer Diagnostic Technologies revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Breast Cancer Diagnostic Technologies revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Abbott
Bristol-Myers Squibb
Agilent Technologies
Novartis
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Breast Cancer Diagnostic Technologies, market overview.
Chapter 2: Global Breast Cancer Diagnostic Technologies market size in revenue.
Chapter 3: Detailed analysis of Breast Cancer Diagnostic Technologies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Breast Cancer Diagnostic Technologies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Breast Cancer Diagnostic Technologies Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Breast Cancer Diagnostic Technologies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Breast Cancer Diagnostic Technologies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Breast Cancer Diagnostic Technologies Overall Market Size
2.1 Global Breast Cancer Diagnostic Technologies Market Size: 2022 VS 2029
2.2 Global Breast Cancer Diagnostic Technologies Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Breast Cancer Diagnostic Technologies Players in Global Market
3.2 Top Global Breast Cancer Diagnostic Technologies Companies Ranked by Revenue
3.3 Global Breast Cancer Diagnostic Technologies Revenue by Companies
3.4 Top 3 and Top 5 Breast Cancer Diagnostic Technologies Companies in Global Market, by Revenue in 2022
3.5 Global Companies Breast Cancer Diagnostic Technologies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Diagnostic Technologies Players in Global Market
3.6.1 List of Global Tier 1 Breast Cancer Diagnostic Technologies Companies
3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Diagnostic Technologies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Breast Cancer Diagnostic Technologies Market Size Markets, 2022 & 2029
4.1.2 Mammography
4.1.3 Biopsy
4.1.4 Companion Diagnostics
4.2 By Type - Global Breast Cancer Diagnostic Technologies Revenue & Forecasts
4.2.1 By Type - Global Breast Cancer Diagnostic Technologies Revenue, 2018-2023
4.2.2 By Type - Global Breast Cancer Diagnostic Technologies Revenue, 2024-2029
4.2.3 By Type - Global Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Breast Cancer Diagnostic Technologies Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Breast Cancer Diagnostic Technologies Revenue & Forecasts
5.2.1 By Application - Global Breast Cancer Diagnostic Technologies Revenue, 2018-2023
5.2.2 By Application - Global Breast Cancer Diagnostic Technologies Revenue, 2024-2029
5.2.3 By Application - Global Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Breast Cancer Diagnostic Technologies Market Size, 2022 & 2029
6.2 By Region - Global Breast Cancer Diagnostic Technologies Revenue & Forecasts
6.2.1 By Region - Global Breast Cancer Diagnostic Technologies Revenue, 2018-2023
6.2.2 By Region - Global Breast Cancer Diagnostic Technologies Revenue, 2024-2029
6.2.3 By Region - Global Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Breast Cancer Diagnostic Technologies Revenue, 2018-2029
6.3.2 US Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.3.3 Canada Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.3.4 Mexico Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Breast Cancer Diagnostic Technologies Revenue, 2018-2029
6.4.2 Germany Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.4.3 France Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.4.4 U.K. Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.4.5 Italy Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.4.6 Russia Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.4.7 Nordic Countries Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.4.8 Benelux Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Breast Cancer Diagnostic Technologies Revenue, 2018-2029
6.5.2 China Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.5.3 Japan Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.5.4 South Korea Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.5.5 Southeast Asia Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.5.6 India Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Breast Cancer Diagnostic Technologies Revenue, 2018-2029
6.6.2 Brazil Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.6.3 Argentina Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Breast Cancer Diagnostic Technologies Revenue, 2018-2029
6.7.2 Turkey Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.7.3 Israel Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.7.4 Saudi Arabia Breast Cancer Diagnostic Technologies Market Size, 2018-2029
6.7.5 UAE Breast Cancer Diagnostic Technologies Market Size, 2018-2029
7 Breast Cancer Diagnostic Technologies Companies Profiles
7.1 Abbvie
7.1.1 Abbvie Company Summary
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Breast Cancer Diagnostic Technologies Major Product Offerings
7.1.4 Abbvie Breast Cancer Diagnostic Technologies Revenue in Global Market (2018-2023)
7.1.5 Abbvie Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Breast Cancer Diagnostic Technologies Major Product Offerings
7.2.4 Abbott Breast Cancer Diagnostic Technologies Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Breast Cancer Diagnostic Technologies Major Product Offerings
7.3.4 Bristol-Myers Squibb Breast Cancer Diagnostic Technologies Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Company Summary
7.4.2 Agilent Technologies Business Overview
7.4.3 Agilent Technologies Breast Cancer Diagnostic Technologies Major Product Offerings
7.4.4 Agilent Technologies Breast Cancer Diagnostic Technologies Revenue in Global Market (2018-2023)
7.4.5 Agilent Technologies Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Breast Cancer Diagnostic Technologies Major Product Offerings
7.5.4 Novartis Breast Cancer Diagnostic Technologies Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Breast Cancer Diagnostic Technologies Major Product Offerings
7.6.4 Pfizer Breast Cancer Diagnostic Technologies Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Breast Cancer Diagnostic Technologies Market Opportunities & Trends in Global Market
Table 2. Breast Cancer Diagnostic Technologies Market Drivers in Global Market
Table 3. Breast Cancer Diagnostic Technologies Market Restraints in Global Market
Table 4. Key Players of Breast Cancer Diagnostic Technologies in Global Market
Table 5. Top Breast Cancer Diagnostic Technologies Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Breast Cancer Diagnostic Technologies Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Breast Cancer Diagnostic Technologies Revenue Share by Companies, 2018-2023
Table 8. Global Companies Breast Cancer Diagnostic Technologies Product Type
Table 9. List of Global Tier 1 Breast Cancer Diagnostic Technologies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Breast Cancer Diagnostic Technologies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Breast Cancer Diagnostic Technologies Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Breast Cancer Diagnostic Technologies Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Breast Cancer Diagnostic Technologies Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Breast Cancer Diagnostic Technologies Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Breast Cancer Diagnostic Technologies Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Breast Cancer Diagnostic Technologies Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2024-2029
Table 30. Abbvie Company Summary
Table 31. Abbvie Breast Cancer Diagnostic Technologies Product Offerings
Table 32. Abbvie Breast Cancer Diagnostic Technologies Revenue (US$, Mn) & (2018-2023)
Table 33. Abbvie Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Breast Cancer Diagnostic Technologies Product Offerings
Table 36. Abbott Breast Cancer Diagnostic Technologies Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Breast Cancer Diagnostic Technologies Product Offerings
Table 40. Bristol-Myers Squibb Breast Cancer Diagnostic Technologies Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. Agilent Technologies Company Summary
Table 43. Agilent Technologies Breast Cancer Diagnostic Technologies Product Offerings
Table 44. Agilent Technologies Breast Cancer Diagnostic Technologies Revenue (US$, Mn) & (2018-2023)
Table 45. Agilent Technologies Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Breast Cancer Diagnostic Technologies Product Offerings
Table 48. Novartis Breast Cancer Diagnostic Technologies Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Breast Cancer Diagnostic Technologies Product Offerings
Table 52. Pfizer Breast Cancer Diagnostic Technologies Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Key News & Latest Developments
List of Figures
Figure 1. Breast Cancer Diagnostic Technologies Segment by Type in 2022
Figure 2. Breast Cancer Diagnostic Technologies Segment by Application in 2022
Figure 3. Global Breast Cancer Diagnostic Technologies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Breast Cancer Diagnostic Technologies Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Breast Cancer Diagnostic Technologies Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Breast Cancer Diagnostic Technologies Revenue in 2022
Figure 8. By Type - Global Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
Figure 9. By Application - Global Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
Figure 10. By Type - Global Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
Figure 12. By Application - Global Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
Figure 14. By Region - Global Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
Figure 15. By Country - North America Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
Figure 16. US Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
Figure 20. Germany Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 21. France Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
Figure 28. China Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 32. India Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
Figure 34. Brazil Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Breast Cancer Diagnostic Technologies Revenue Market Share, 2018-2029
Figure 37. Turkey Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Breast Cancer Diagnostic Technologies Revenue, (US$, Mn), 2018-2029
Figure 41. Abbvie Breast Cancer Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Breast Cancer Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Breast Cancer Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Agilent Technologies Breast Cancer Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Breast Cancer Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Breast Cancer Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
